BCC Survivorship Research Grant -LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: RIS Review not required for LOI
External Deadline: Friday 31st, July 2026
Description
Breast Cancer Canada, in partnership with AstraZeneca Canada, is now accepting applications for two matched research awards focused on improving breast cancer survivorship care across Canada. This funding supports innovative, Canadian-led research that addresses critical gaps following primary treatment, with an emphasis on real-world impact and improved patient outcomes. We are seeking proposals focused on:
- Breast cancer survivorship surveillance and diagnostics
- Therapeutic interventions in post-treatment care
- New care delivery models that improve transitions between community and specialty services
Application Details:
- 2 awards of $100,000 CAD each
- LOI Deadline is July 31, 2026
- Invited Grant Submission Due: September 11, 2026
- Full details, eligibility criteria, and application instructions are available: